Keith Woods

Insider Reports History

Location
Boston, MA
Signature
/s/ Zoran Zdraveski, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Woods:

Company Role Class Num Shares Value Price $ Report Date Ownership
Scholar Rock Holding Corp Chief Operating Officer Common Stock 600,000 $19,290,000 $32.15 27 Apr 2025 Direct
ROCKET PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 23,944 $360,118 $15.04 13 Jun 2024 Direct
X4 Pharmaceuticals, Inc Director Common Stock 6,000 $1,140 $0.1900 09 Jun 2025 Direct
Scholar Rock Holding Corp Chief Operating Officer Stock Option (Right to Buy) 110,067 02 May 2025 Direct
TScan Therapeutics, Inc. Director Stock Option (Right to Buy) 67,000 30 Jun 2025 Direct

Insider Reports Filed by Keith Woods

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TCRX TScan Therapeutics, Inc. 30 Jun 2025 1 $0 4 Director 02 Jul 2025, 16:30
XFOR X4 Pharmaceuticals, Inc 09 Jun 2025 1 $0 4 Director 10 Jun 2025, 16:30
SRRK Scholar Rock Holding Corp 02 May 2025 1 $0 4 Chief Operating Officer 06 May 2025, 17:02
SRRK Scholar Rock Holding Corp 27 Apr 2025 2 $0 4 Chief Operating Officer 29 Apr 2025, 18:10
SRRK Scholar Rock Holding Corp 27 Apr 2025 0 $0 3 Chief Operating Officer 29 Apr 2025, 18:01
RCKT ROCKET PHARMACEUTICALS, INC. 13 Jun 2024 1 $0 4 Director 20 Jun 2024, 16:10
TCRX TScan Therapeutics, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:20
XFOR X4 Pharmaceuticals, Inc 10 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:12
RCKT ROCKET PHARMACEUTICALS, INC. 07 Dec 2023 2 $0 4 Director 12 Dec 2023, 20:51
RCKT ROCKET PHARMACEUTICALS, INC. 07 Dec 2023 0 $0 3 Director 12 Dec 2023, 20:42
TCRX TScan Therapeutics, Inc. 06 Dec 2023 1 $0 4 Director 08 Dec 2023, 08:20
TCRX TScan Therapeutics, Inc. 06 Dec 2023 0 $0 3 Director 08 Dec 2023, 08:15
XFOR X4 Pharmaceuticals, Inc 16 Oct 2023 1 $0 4 Director 18 Oct 2023, 16:02
XFOR X4 Pharmaceuticals, Inc 16 Oct 2023 0 $0 3 Director 18 Oct 2023, 16:00